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The Efficacy of Electroconvulsive Therapy in Managing
Self-Injurious Behaviors Among Youth with Autism Spectrum
Disorder: A Review
Themal Ellawala
Themal Ellawala is a Psychology major with a special interest in the intersection of
Clinical Psychology and social justice. He is particularly interested in the prevalence of mental health issues in racial and sexual minorities, and how stigma and
discrimination leads to poorer outcomes among such demographics. He is currently involved in studies in Clark’s Hyatt School of Psychology examining internalized psychopathology, effective interventions to mediate relationship stress, and
volunteers in Clark’s CAVE program. He hails from Colombo, Sri Lanka, and
hopes to use his research to create greater awareness of sexual minorities who live
in the shadows of his country.

Abstract

Self-Injurious Behaviors (SIB) in Autism Spectrum Disorder (ASD) form a constellation of particularly pervasive
and harmful symptoms signifying high morbidity for children and adolescents. Electroconvulsive Therapy (ECT)
has been proposed as a last resort for particularly severe and treatment-resistant forms of SIB, yet has received little
acceptance in mainstream clinical psychology. This paper summarizes findings of four studies investigating the efficacy of ECT in treating SIB in ASD inflicted youth. This paper also evaluates the research on potential side-effects
and ethical implications of ECT use. I conclude that while extensive further research is required to understand the
implications of usage, that ECT may bear the potential to benefit an erstwhile untreated population.

Introduction

of a variety of consequences from
Children with Autism Spec- SIB, the most detrimental are tissue
damage, disfigurement, health risks
trum Disorder (ASD) present a distinctive set of symptoms which affect due to infection, and stigmatizing
consequences (Humenik, Curran,
areas of socialization, communication, and volition (American Psychi- Luiselli, & Child, 2008). There
exists considerable debate on the
atric Association, 2013). Of these,
prevalence of SIB in ASD. The
Self-Injurious Behaviors (SIB) may
be one of the most grave. Self-Injuri- research of Janicki and Jacobson
ous Behaviors are defined as, “a class (1983) posited that 20% of children
diagnosed with autism display some
of behaviors, often highly repetitive
and rhythmic, that result in physical form of SIB. In contrast, the more
recent findings of Baghdadli, Pascal,
harm to the individual displaying
the behavior” (Fee & Matson, 1992, Grisi, and Aussilloux (2003) indicated that SIB is prevalent in 50%
4). These repetitive behaviors inof children with ASD, with 14.6%
clude pulling hair or skin, picking
demonstrating SIB at severe levels.
skin, biting self, inserting fingers
A number of hypotheses
or objects into bodily orifices, and
attempt
to illustrate the etiology
other hand-to-head and hand-tobody injuries (Lam & Aman, 2007). of SIB while little consensus exists within the clinical ranks on
Researchers have concluded that
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treatment. This is indicated by the
controversy that surrounds the use of
Electroconvulsive Therapy (ECT) in
treating severe forms of this condition. A negative view of the therapy,
reinforced by representations in
popular culture, has been enshrined
in the laws of states such as California, Colorado, Tennessee, and
Texas, to name a few (Consoli, et
al., 2012). Meanwhile, some authors
have augmented these concerns
by stating their opposition to the
practice for ethical reasons and the
risk of various secondary cognitive
side effects (Baker, 1995). Nonetheless, experts have concluded that
alternative therapies, such as psychotropic medication and behavioral
therapy do not succeed in treating
all patients (Food and Drugs Ad-

Positive-only Treatment of
Self-Injurious Behaviors

First line interventions for
SIB in ASD consists of a combination of behavioral and psychopharmacological treatments (Weiss,
2002). These first line interventions
have proven to be effective when
observable environmental circumstances appear to be maintaining
the behaviors, or if an underlying
psychotropic condition is present
(Weiss, 2002). However, several
clinical phenomena challenge the
therapeutic primacy of first line
interventions. Efficacy of these
therapies differ from one clinical
case to another due to the highly
individualized nature of SIB in
ASD (McCorkle, 2011). An added complication is that only two
antipsychotics, aripiprazole and
risperidone, have been approved by
the FDA for use in treating behavioral impairments associated with
autism and/or intellectual disabilities
in children and adolescents (Consoli,
et al., 2012). This is due, in part, to
the significant side effects associated
with antipsychotic use. Indeed, two
meta-analyses of randomized, placebo-controlled trials of antipsychotics
among children (Cohen, Bonnot,
Bodeau, Consoli, & Laurent, 2012;
De Hert, Dobbelaere, Sheridan,
Cohen, & Correll, 2011), including
aripiprazole and risperidone, have

demonstrated that antipsychotic
usage is linked to short term extrapyramidal symptoms (movement disorders such as restlessness,
involuntary muscle contractions,
pseudo-parkinsonism), cardio-metabolic and endocrine side-effects, hyperprolactinaemia (elevated levels of
the hormone prolactin), and weight
gain (Cohen, Bonnot, Bodeau, Consoli, & Laurent, 2012). Lastly some
patients display particularly severe
forms of first line treatment-resistant
SIB (Consoli, et al., 2012). It is this
population that researchers look to
in the debate on ECT.

The Efficacy of
Electroconvulsive Therapy

Despite the controversy that
surrounds the use of ECT, a number
of studies have demonstrated significant treatment effects in cases of
severe and treatment-resistant mood
disorders (Ghaziuddin, Dumas &
Hodges, 2011; Kessler, 2004; Ligas,
Petrides, Istafanous & Kellner, 2009;
Reinblatt, Rifkin & Freeman, 2004).
The literature on clinical benefits
of ECT use in cases of maladaptive
behavioral conditions, especially in
ASD, is considerably more sparse
but warrants assessment. What
follows is a summary of four studies
– all of which involve small sample
sizes – that demonstrate significant
treatment benefits of ECT in cases
of severe SIB.
The case of a sixteen year
old male diagnosed with autism,
catatonic symptoms, and severe SIB
demonstrates the dramatic treatment
effects of ECT (Haq & Ghaziuddin,
2014). The patient had been hospitalized due to an acute increase in
SIB, such as biting himself, throwing
himself against walls, and banging
his head. After over a month of admission and the failure of pharmacological and behavioral management

therapies, the patient was referred
to ECT treatment. This resulted in
gradual but dramatic improvement
with aggressive episodes declining
enough by the 16th session to allow
for hospital discharge, school attendance, and out-patient treatment. The
tapering of treatment occurred over
the next four months and ended
with termination upon which the
patient experienced a gradual decline
in functioning and an increase in
SIB. This development necessitated
the reinstatement of ECT, which
resulted in an immediate decrease
in problematic behaviors and an
increase in functioning. The tapering
of the second treatment course resulted in the same pattern of regression, which could not be mediated
by antiepileptics. Electroconvulsive
therapy was restarted again, leading
to an immediate cessation of SIB,
and a more effective tapering schedule was identified. This case highlights the efficacy of ECT in managing SIB and identifies the need
for additional research into effective
maintenance schedules and tapering
trajectories for this particular treatment method.
The clinical case of an
eight year old boy with autism,
who presented a five-year history
of extreme self-injury supports the
findings of the previous research
(Wachtel, et al., 2009). The patient’s
SIB included slapping and punching
his head, as well as banging his head
on his knees and shoulders, with the
frequency averaging 109.3 attempts
hourly. Despite undergoing extensive applied behavioral assessments,
medication, and behavioral trials
for three years, the patient showed
little to no decrease in SIB. He also
displayed significant mood instability, with negative affect correlated
to increase in SIB. Fifteen ECT
treatments were administered over a
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ministration, 2014). The severity of
SIB and its consequences heightens
the need to determine the effectiveness of ECT. The focus of this paper
is to evaluate existing literature on
the use of ECT to treat SIB, ASD
youths. This review of material will
be used in an attempt to assess and
draw conclusions on the efficacy and
ethical considerations of this practice
while taking into account the unique
population in question.

20
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period of five weeks, three times per
week with tapering towards the end.
Significant improvement was noted
after the first session alone. Overall,
the rate of self-injury was reduced to
6.5 attempts hourly with restraints
and 19.4 without restraints. The restraints required were canvas sleeves
and not the bilateral arm restraints
and cervical immobilizer that were
worn before treatment.
Similarly, the case of an
eleven year old boy diagnosed with
autism and concomitant psychotropic-resistant bipolar affective disorder
demonstrates the efficacy of ECT in
reducing severe SIB (Wachtel, Jaffe,
& Kellner, 2011). Self-Injurious
Behaviors consisted of a several-year
history of hand-to-head injury,
resulting in bleeding, a broken arm,
and repeated hand-biting. Several
years of extensive psychopharmacological interventions had failed
to produce any lasting results so an
acute ECT treatment was initiated,
consisting of eight sessions over a
course of 2.5 weeks. After the end
of the acute treatment, clinical and
parent observations recorded near
extinction of SIB. Maintenance therapy of once weekly sessions led to an
intense violent outburst on Day 6
post-acute treatment. The frequency
of maintenance therapy was then
increased leading to previously noted
behavioral and affective stabilization
and a return to normal, educational,
and social activities.
The efficacy of ECT was
demonstrated in the final case, to
treat the catatonic symptoms of a
teenage girl diagnosed with autism,
who developed severe SIB at an early
age (Wachtel, Kahng, Dhossche,
Cascella, & Reti, 2008). Handto-head, knee-to-head, and handto-body self-injury were the most
prevalent behaviors observed, intensifying in frequency to hundreds
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of times hourly. The failure of multiple psychopharmacological therapies led to the use of ECT with 25
treatments administered three times
per week, and tapering to maintenance levels. Self-Injurious Behaviors
was reported to have markedly decreased by the ninth treatment and
neared extinction towards the end of
the therapy. Clinicians experimented
with the placement of the leads, and
discovered that bilateral placement
delivered the best results. This highlights the need for further research in
the clinical benefits of bilateral lead
placement in ECT.
In addition to these studies,
a number of other clinical cases have
revealed the significant treatment effects of ECT in managing severe psychological disorders with concomitant SIB (Black, Wilcox, & Stewart,
1985; Carr, Dorrington, Schrader,
& Wale, 1983; Chung & Varghese,
2008; Cizadlo & Wheaton, 1995;
Fink, 1999; Thuppal & Fink, 1999).
Of these, the most relevant to this
review are studies examining SIB
and concomitant intellectual disabilities (ID). A wealth of knowledge
exists to demonstrate the overlap
and similarities between ID and
ASD as risk factors for predicting
SIB (Bartak, Rutter, & Michael,
1976; McClintock, Hall, & Oliver,
2003). A retrospective study of the
efficacy of ECT in treating severe
and treatment- resistant SIB among
a small sample of adolescents with
ID (n=4) showed promising results
(Consoli, et al., 2012). The SIB
reported was severe in scale and included repeated attempts of suicide,
repeated head banging, attempts to
remove an eye with a fork, and daily
ingestion of objects. When comparing the efficacy of ECT, mean SIB
scores post-ECT were shown to be
half of pre-ECT values. Three of the
four patients transitioned to fewer

restrictive environments, indicating
the success of ECT in treating SIB in
conditions highly related to ASD.
Despite the relative success of ECT in treating SIB, little
knowledge exists on the underlying
reasons of its efficacy. Researchers
have presented several neurobiological hypotheses, one being that
SIB in some cases can be explained
by monoamine dysfunction, which
could potentially be reversed by
ECT (Sanacora, et al., 2003). This
theory posits that the treatment has
been shown to increase GABA-ergic
transmission, which other research
indicates may correct the lack of
GABA-led inhibition displayed in
SIB (Schroeder, et al., 2001). Furthermore, decreased dopamine and
serotonin activity in SIB (Schroeder,
et al., 2001) could be ameliorated by
ECT (Yoshida, et al., 1998). Lastly,
researchers have suggested that ECT
achieves the normalization of HPA
axis activity in SIB (Fink, 1999).
Thus, evidence exists to support the
theoretical conceptualization of the
treatment efficacy of ECT in severe
SIB.

Risks and Ethical
Implications of ECT
Treatment

Proponents of the use of
ECT claim that misperceptions
regarding the treatment have biased
mainstream clinical thought, leading
to the underutilization of a purportedly effective therapy. The American Psychiatric Association (APA)
and the American Academy of Child
and Adolescent Psychiatry (AACAP)
consider ECT to be a viable option
for children with certain affective,
psychotic, and catatonic disorders
(Consoli, et al., 2012). In 2004, the
AACAP issued practice parameters
on ECT in adolescence (AACAP Of-

may be at lesser risk than adults,
who may have pre-existing medical
conditions or risk factors (Wachtel,
Dhosscheb, & Kellner, 2011). Most
importantly, no pediatric deaths
have been reported due to ECT (Rey
& Walter, 1997). This suggests that
while concerns of mild medical and
physical risks exist, that they can be
effectively managed by clinicians.
The second category of risks
deals with cognitive and memory
impairment. Park’s review of literature demonstrates that immediate
cognitive dysfunction, in the form
of disorientation, may occur. This
effect is observed to be transient and
is expected to cease within minutes
after treatment. Memory dysfunction is a more significant risk and
deserves greater exploration. The
research of Krulewitch and Como
(2011) that was presented before
the same FDA panel suggests that
anterograde verbal memory deficits
may result through ECT, which
generally resolves within a few weeks
post-treatment. Of greater concern, according to Krulewitch and
Como, is the risk of autobiographical memory deficits, with evidence
suggesting that autobiographical
memory performance is approximately 76-77% of baseline performance for right unilateral treatment
and 58-67% for bilateral treatment.
This is particularly significant as
Wachtel and colleagues suggested
the potential efficacy of bilateral lead
placement in ECT (Wachtel, Kahng,
Dhossche, Cascella, & Reti, 2008).
Conflicting with this finding, two
separate studies (Wachtel, Hermida,
A, & Dhossche, 2010; Wachtel,
Reti, Dhossche, Slomine, & Sanz,
2011) maintain that bilateral placement, even when continued over
several years, did not lead to cognitive impairments. This highlights
the need for additional research to

resolve this point of contention.
Several factors may mitigate this particular risk, such as the use of certain
types of currents (Food and Drugs
Administration, 2011).
Research into risk of retrograde amnesia post-ECT have
concluded that while a loss of
memory is observed immediately
after treatment, by 3 months, retrograde memory had reached baseline
levels and that anterograde memory
appeared to be unaffected (Meeter,
Murreb, Janssen, Birkenhager, & van
den Broek, 2011). A study assessing
learning and memory impairment
among adult patients undergoing
ECT for Bipolar Disorder shows
that, even after adjusting for the
inherent memory and learning
dysfunction associated with the
disorder, patients reported lower
performance (MacQueen, Parkin, &
Marriott, 2007). While the researchers have stated that this finding is
unlikely to alter the risk-benefit
ratio of the treatment significantly,
it does highlight the importance of
attending to the cognitive factors of
patients before and following treatment. One significant finding from
this research is that patients receiving
ECT are more likely to self-report
memory impairment, which speaks
for expectations which could affect their performance in tests in a
self-fulfilling prophecy effect. If this
hypothesis is likely to be true, managing patient expectations regarding
ECT treatment could mitigate risks
of memory impairment significantly.
A study assessing cognitive functioning of adolescents with severe treatment-resistant depression arrived
at a contradictory result, indicating
evidence of improved short-term
memory and verbal learning as well
as a statistically significant improvement in long-term delayed memory
recall (Ghaziuddin, Dumas, &
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ficial, 2004). Nonetheless, a review
of the literature concerning potential
side-effects of ECT has been incorporated in this paper. Here I wish to
note the paucity of literature exploring the side-effects of ECT when
applied to youth with ASD and SIB.
Many of the studies reviewed in this
section consider the risks posed to
all populations undergoing treatment, even adults and those with
other conditions. However, it may
be possible to draw inferences for
the specific population in question
through this analysis.
The potential risks that ECT
poses to any population can be
divided into three broad categories
according to the review of literature
presented by Lawrence Park before
the FDA Neurological Devices Panel
in a deliberation of the reclassification of ECT (Food and Drugs
Administration, 2011). Of these,
the third category, one dealing with
device malfunction, has been omitted from this review in the interest
of brevity. According to Park, the
medical and physical risks of ECT
include adverse reactions to anesthesia, cardiovascular complications,
dental and oral trauma, physical
trauma, pulmonary complications,
skin burns, and strokes. These are
classified as uncommon side effects
and the risks of occurrence can be
minimized by pre-ECT medical
tests, assessments, gaining a detailed
medical, surgical, and family history, and post-ECT monitoring and
clinical management. Alterations in
blood pressure pain, and discomfort
are the two most common physical
side effects – both reported to be benign and transient in nature – which
clinicians have to account for (Food
and Drugs Administration, 2011).
With regard to certain side effects
such as cardiovascular complications,
other research suggests that children
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Hodges, 2011). These findings could
perhaps be attributed to symptom
relief, positive effect, greater motivation and increased psychomotor
control that results through high
treatment efficacy. Despite contradictory findings, proponents of
ECT argue that enough research has
been conducted to dismiss the more
serious claims of long term cognitive
and memory impairment among
youth (Cohen, et al., 2000; Ghaziuddin, et al., 1996; Walter, Koster,
& Rey, 1999).
With regard to the ethical
implications of ECT use, guidelines
such as those put forth by the
AACAP confirm the importance of
gaining the consent of parents/legal
guardians and the patients. Emphasis is placed on educating both
the patient and the parents/guardians on the benefits and risks of the
treatment and granting both parties
the right to reject treatment at any
time once therapy has commenced.
The consulting of an independent
psychiatrist is another safeguard
that has been instated, along with
a seventy-two hour waiting period
before treatment begins, allowing the
patient and parents/guardians time
to reflect on their choice. A potential ethical dilemma – one faced by
all child mental health practitioners – arises if the patient and the
parents disagree. If the use of ECT
was to become more accepted, a
question that requires consensus is
at what point SIB is declared to be
treatment-resistant and is referred to
ECT. As the focus on early interventions in SIB in ASD grows, it must
be decided if there is any age that is
considered too young for receiving
ECT. Lastly, although clinicians are
quick to declare pain experiences
to be mild to moderate (Food and
Drugs Administration, 2011) any
potential significant pain occurring
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through ECT warrants attention
given the ethical implications of
subjecting children to treatment that
is potentially painful. A growing
body of research is challenging the
misconception that ASD is associated with higher pain thresholds
or pain insensitivity (Allely, 2013).
This research suggests that children
with ASD may express pain in ways
different to neurotypical children,
which may lead to an underestimation of pain experience. This is
particularly relevant to the sub-population of patients with severe
intellectual disabilities. Thus, further
research is required to accurately
gauge pain experience.
While it is important to bear in
mind the potential physical and cognitive impairments that may occur as
a result of ECT usage, active management of such situations, and adherence to clinically tested guidelines
may offer clinician the opportunity
to minimize potential hazards.

the dearth of research examining
the unique side-effects that youth
with ASD and SIB experience when
undergoing ECT, another limitation imposed upon this review was
having to generalize side-effects of
ECT use in other conditions to this
particular context. Additionally,
the studies that were reviewed were
conducted over the past five decades,
and thus there may exist varying
standards in the quality of research
and analysis, with a general trend of
improvement over time. While every
effort was made to use more recent
materials, this limitation cannot
be discounted. Related to this is
an additional concern of varying
diagnostic definitions and criteria as
well as assessment tools being used
across studies, potentially contributing to low reliability, validity and
comparability. Lastly, all of the research on efficacy and complications
of ECT are single subject designs
with no controlled trials, which may
affect the generalizability of findings.
It is, therefore, imperative
Discussion
that
more
research involving larger
A summary of the literature
samples is conducted on the efficacy
that exists on the subject of manof ECT (e.g. unilateral vs. bilateral
aging and treating SIB of children
placement, tapering trajectories) and
and adolescents with ASD, demonstrates that there is some evidence for potential side effects (e.g. pain experience, mitigating effects on autobiothe efficacy of ECT as a last-resort
graphical memory among others). It
intervention for particularly severe
is of utmost importance that future
and treatment-resistant cases. Howresearch study populations of youth
ever, there are limitations to this review that must be taken into account with ASD and symptoms of SIB specifically. While further research along
when interpreting the results. First,
streamlined, uniform, and universal
there is the possibility of certain
relevant research being overlooked in standards is required to conclude
the review process. It is of particular authoritatively on the question of
ECT use, the research exhibiting
significance that no research was
found to reveal the ineffectiveness or the treatment gains and risk-management capabilities of ECT cannot
substantial risks of ECT in treating
be denied. Therefore, this treatment
SIB in ASD. This may be explained
carries significant potential to offer
by the limitation elucidated earlier,
relief to those who do not respond to
but it is notable that there is no
first-line interventions and have little
easily available wealth of knowledge
hope.
supporting this position. Given
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